FFCP PHASE2:Hg19::chr12:98909351..98909454,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p1@TMPO |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_1_at_TMPO_5end |
| Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
| Association with transcript: | 0bp_to_ENST00000266732, ENST00000343315, ENST00000393053, ENST00000546828, ENST00000548911, NM_001032283, NM_001032284, NM_003276, uc001tfh.1, uc001tfi.1, uc001tfj.2, uc001tfk.2, uc001tfl.2_5end |
| EntrezGene: | TMPO |
| HGNC: | 11875 |
| UniProt: | P42166G5E972P42167Q59G12A2T926 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@TMPO |
|---|
0
100
200
300
400
500
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| lymphocyte | 4.81e-10 | 53 |
| common lymphoid progenitor | 4.81e-10 | 53 |
| lymphoid lineage restricted progenitor cell | 1.53e-09 | 52 |
| lymphocyte of B lineage | 3.71e-07 | 24 |
| pro-B cell | 3.71e-07 | 24 |
Showing 1 to 5 of 5 entries
| Ontology term | p-value | n |
|---|---|---|
| cancer | 1.43e-42 | 235 |
| disease of cellular proliferation | 5.65e-40 | 239 |
| cell type cancer | 2.00e-23 | 143 |
| hematologic cancer | 1.89e-22 | 51 |
| immune system cancer | 1.89e-22 | 51 |
| organ system cancer | 6.48e-21 | 137 |
| carcinoma | 8.14e-20 | 106 |
| leukemia | 1.43e-18 | 39 |
| myeloid leukemia | 9.19e-14 | 31 |
Showing 1 to 9 of 9 entries
